Inactive Instrument

20/20 GeneSystems Inc.

Equities

TWTG

US90215Y1073

20/20 GeneSystems Inc. announced that it has received funding from BHC Center Of Financial & Investment Business LLC

August 18, 2014

20/20 GeneSystems, Inc. announced that it has received equity funding from new investor BHC Center of Financial & Investment Business LLC on August 18, 2014.

On August 18, 2014, 20/20 GeneSystems, Inc. closed the transaction.

Latest news about 20/20 GeneSystems Inc.

20/20 GeneSystems, Inc. announced that it expects to receive $5.000002 million in funding	06/05	CI
20/20 GeneSystems Inc. announced that it expects to receive $4.999995 million in funding	15/22/15	CI
20/20 GeneSystems, Inc. Launches First Accelerator Facility for Innovative Clinical Lab Tests	28/21/28	CI
20/20 GeneSystems, Inc. announced that it has received $2 million in funding	04/16/04	CI
20/20 GeneSystems, Inc. announced that it expects to receive $3 million in funding.	28/16/28	CI
20/20 GeneSystems, Inc. announced that it has received $4.5 million in funding from Ping An Ventures and other investors.	14/16/14	CI
20/20 GeneSystems, Inc. announced that it expects to receive $4 million in funding from Ping An Ventures.	31/14/31	CI
20/20 GeneSystems Inc. announced that it has received funding from BHC Center Of Financial & Investment Business LLC	18/14/18	CI

Chart 20/20 GeneSystems Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company